Praveen Tyle is a director of Kiora Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Skye Bioscience, Inc.
4 Mar 24
4
Skye Bioscience, Inc.
6 Nov 23
4
KIORA PHARMACEUTICALS INC
3 Oct 23
4
Skye Bioscience, Inc.
29 Aug 23
4
KIORA PHARMACEUTICALS INC
7 Mar 23
4/A
Skye Bioscience, Inc.
9 Jan 23
4
Skye Bioscience, Inc.
6 Jan 23
4
KIORA PHARMACEUTICALS INC
3 Feb 22
4
Skye Bioscience, Inc.
16 Sep 21
4
Skye Bioscience, Inc.
26 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Feb 24 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 14.56 | 35,000 | 509.60 k | 35,000 |
6 Nov 23 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 14,110 | 49.39 k | 20,001 |
29 Sep 23 | KPRX Kiora Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5677 | 5,000 | 2.84 k | 5,000 |
25 Aug 23 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 0.014 | 1,472,692 | 20.62 k | 1,472,692 |
3 Mar 23 | KPRX Kiora Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.83 | 8,000 | 30.64 k | 8,000 |